Suramin in Treating Patients With Recurrent Bladder Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
RATIONALE: Suramin may stop the growth of bladder cancer by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of suramin in treating patients who have recurrent bladder cancer.
Epistemonikos ID: ccec215a64f66c096df1714a9a28637d6517f175
First added on: May 03, 2024